DK258884A - Peptider og farmaceutisk praeparat indeholdende et saadant peptid - Google Patents

Peptider og farmaceutisk praeparat indeholdende et saadant peptid Download PDF

Info

Publication number
DK258884A
DK258884A DK258884A DK258884A DK258884A DK 258884 A DK258884 A DK 258884A DK 258884 A DK258884 A DK 258884A DK 258884 A DK258884 A DK 258884A DK 258884 A DK258884 A DK 258884A
Authority
DK
Denmark
Prior art keywords
sup
hydrogen
peptides
peptid
carbamyl
Prior art date
Application number
DK258884A
Other languages
English (en)
Other versions
DK258884D0 (da
Inventor
George William Hardy
Lawrence Alfred Lowe
Terence William Smith
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK258884D0 publication Critical patent/DK258884D0/da
Publication of DK258884A publication Critical patent/DK258884A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK258884A 1983-05-26 1984-05-25 Peptider og farmaceutisk praeparat indeholdende et saadant peptid DK258884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838314646A GB8314646D0 (en) 1983-05-26 1983-05-26 Pharmaceutical amides

Publications (2)

Publication Number Publication Date
DK258884D0 DK258884D0 (da) 1984-05-25
DK258884A true DK258884A (da) 1984-11-27

Family

ID=10543432

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258884A DK258884A (da) 1983-05-26 1984-05-25 Peptider og farmaceutisk praeparat indeholdende et saadant peptid

Country Status (17)

Country Link
US (1) US4540682A (da)
EP (1) EP0127154B1 (da)
JP (1) JPS59231053A (da)
KR (1) KR850000467A (da)
AT (1) ATE57188T1 (da)
AU (1) AU575324B2 (da)
CA (1) CA1251898A (da)
DE (1) DE3483338D1 (da)
DK (1) DK258884A (da)
ES (2) ES8606395A1 (da)
FI (1) FI82254C (da)
GB (1) GB8314646D0 (da)
GR (1) GR81890B (da)
HU (1) HU193569B (da)
IL (1) IL71932A (da)
NZ (1) NZ208283A (da)
ZA (1) ZA844004B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622090D0 (en) * 1986-09-12 1986-10-22 Wellcome Found Pharmacologically active compounds
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
WO1994025482A1 (en) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6312893B1 (en) 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
US6027890A (en) 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US6613508B1 (en) 1996-01-23 2003-09-02 Qiagen Genomics, Inc. Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
AU6990796A (en) * 1996-08-23 1998-03-06 Sederma Sa Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
US20100093643A1 (en) * 2006-08-17 2010-04-15 Irina Bobrova Cardioprotective compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178371A (en) * 1977-12-15 1979-12-11 Reckitt & Colman Products Limited Tetrapeptide derivatives
US4288432A (en) * 1979-06-12 1981-09-08 Richter Gedeon Vegyeszeti Gyar Rt. Novel enkephalin analogs and process for the preparation thereof
US4265808A (en) * 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
FI82254B (fi) 1990-10-31
ES545189A0 (es) 1986-03-01
HU193569B (en) 1987-10-28
KR850000467A (ko) 1985-02-27
GB8314646D0 (en) 1983-06-29
ES8606395A1 (es) 1986-04-01
DE3483338D1 (de) 1990-11-08
ATE57188T1 (de) 1990-10-15
FI842104A0 (fi) 1984-05-25
ZA844004B (en) 1986-01-29
ES8604991A1 (es) 1986-03-01
EP0127154A2 (en) 1984-12-05
NZ208283A (en) 1988-07-28
HUT34764A (en) 1985-04-28
EP0127154B1 (en) 1990-10-03
ES532813A0 (es) 1986-04-01
FI82254C (fi) 1991-02-11
FI842104A (fi) 1984-11-27
DK258884D0 (da) 1984-05-25
IL71932A (en) 1987-10-20
JPS59231053A (ja) 1984-12-25
US4540682A (en) 1985-09-10
CA1251898A (en) 1989-03-28
AU575324B2 (en) 1988-07-28
GR81890B (da) 1984-12-12
IL71932A0 (en) 1984-09-30
EP0127154A3 (en) 1987-05-06
AU2870184A (en) 1984-11-29

Similar Documents

Publication Publication Date Title
DK258884D0 (da) Peptider og farmaceutisk praeparat indeholdende et saadant peptid
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
MY100343A (en) Amide derivative and external medicament comprising same
MX171191B (es) Composiciones farmaceuticas de glipizida
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MY101784A (en) Novel pharmacological compounds
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
DK0743940T3 (da) Nye forbindelser med analgetisk og local-anæstetisk virkning
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
SU1832499A3 (ru) Вещество, проявляющее антигипоксическое и антигипотермическое свойства
JO1531B1 (en) New near-compounds
FR2274305A1 (fr) Medicaments a action curative sur les ulceres et leur procede de preparation

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment